Erika Azorín‐Vega

Author

Erika Azorín‐Vega

Instituto Nacional de Investigaciones Nucleares ORCID

Also Known As

E. Azorín-Vega, E.P. Azorín-Vega, Erika Azorín-Vega, Erika Azorín‐Vega, Erika P. Azorin-Vega, Erika P. Azorín-Vega, Erika Patricia Azorin-Vega, Erika Patricia Azorin‐Vega, Erika Patricia Azorín-Vega

Publications

715

Citations

H-Index

Concepts

All Affiliations

Instituto Nacional de Investigaciones Nucleares Universidad Autónoma del Estado de México Instituto Nacional de Cancerología Centro Medico Nacional Siglo XXI Istituto Oncologico Veneto

About

Erika Azorín‐Vega is an author at Instituto Nacional de Investigaciones Nucleares specializing in radiation oncology, medicine, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	289
2	Engineering	7	7	260
3	Biomolecular Engineering	3	3	129
4	Biomedical Engineering	2	2	55
5	Biochemistry	1	1	15

Erika Azorín‐Vega

Publications

582

Citations

H-Index

Page 1

	Year	Citations
Multifunctional targeted therapy system based on <sup>99m</sup>Tc/<sup>177</sup>Lu‐labeled gold nanoparticles‐Tat(49–57)‐Lys<sup>3</sup>‐bombesin internalized in nuclei of prostate cancer cells Nallely Jiménez‐Mancilla, Guillermina Ferro‐Flores, Clara Santos‐Cuevas, Journal of Labelled Compounds and Radiopharmaceuticals	2013	85
Clinical translation of a PSMA inhibitor for 99m Tc-based SPECT Guillermina Ferro‐Flores, Myrna Luna‐Gutiérrez, Blanca Ocampo‐García, Nuclear Medicine and Biology Translational MedicineEngineeringClinical TranslationMedicinePharmacology	2017	76
<sup>177</sup>Lu-Dendrimer Conjugated to Folate and Bombesin with Gold Nanoparticles in the Dendritic Cavity: A Potential Theranostic Radiopharmaceutical Héctor Mendoza-Nava, Guillermina Ferro‐Flores, Flor de Marı́a Ramı́rez, Journal of Nanomaterials NanoparticlesNanotherapeuticsEngineeringLu-labeled NanoparticlesPeptide Science	2016	69
Fluorescent, Plasmonic, and Radiotherapeutic Properties of the <sup>177</sup>Lu–Dendrimer-AuNP–Folate–Bombesin Nanoprobe Located Inside Cancer Cells Héctor Mendoza-Nava, Guillermina Ferro‐Flores, Flor de Marı́a Ramı́rez, Molecular Imaging	2017	47
Design, Synthesis and Preclinical Assessment of 99mTc-iFAP for In Vivo Fibroblast Activation Protein (FAP) Imaging Diana Trujillo-Benítez, Myrna Luna‐Gutiérrez, Guillermina Ferro‐Flores, Molecules	2022	39
Theranostic Radiopharmaceuticals Based on Gold Nanoparticles Labeled with <sup>177</sup>Lu and Conjugated to Peptides Guillermina Ferro‐Flores, Blanca Ocampo‐García, Clara Santos‐Cuevas, Current Radiopharmaceuticals NanoparticlesEngineeringPeptide ScienceProtein NanoparticlesGold Nanoparticles	2015	31
A Therapeutic System of 177Lu-labeled Gold Nanoparticles-RGD Internalized in Breast Cancer Cells Myrna Luna‐Gutiérrez, Guillermina Ferro‐Flores, Blanca Ocampo‐García, Journal of the Mexican Chemical Society NanoparticlesNanotherapeuticsEngineeringPeptide ScienceTherapeutic System	2017	29
Synthesis and evaluation of Lys 1 (α,γ-Folate)Lys 3 ( 177 Lu-DOTA)-Bombesin(1-14) as a potential theranostic radiopharmaceutical for breast cancer Liliana Aranda‐Lara, Guillermina Ferro‐Flores, Erika Azorín‐Vega, Applied Radiation and Isotopes OncologyMedicineTheranosticsLys 1Radiopharmaceutical Therapy	2015	29
Two Novel Nanosized Radiolabeled Analogues of Somatostatin for Neuroendocrine Tumor Imaging Emmanuel Orocio-Rodríguez, Guillermina Ferro‐Flores, Clara Santos‐Cuevas, Journal of Nanoscience and Nanotechnology NanoparticlesEngineeringImaging AgentBiomedical EngineeringProtein Nanoparticles	2014	26
<sup>177</sup>Lu-DOTA-HYNIC-Lys(Nal)-Urea-Glu: Biokinetics, Dosimetry, and Evaluation in Patients with Advanced Prostate Cancer Clara Santos‐Cuevas, Guillermina Ferro‐Flores, Francisco O. García-Pérez, Contrast Media & Molecular Imaging	2018	22

Page 1